Publication | Closed Access

Use of estradiol–progestin therapy associates with increased risk for uterine sarcomas

Uterine SarcomasHormonal ContraceptiveEstradiol–progestin TherapyGynecologyPathologyEndocrinologyMedicineGynecology OncologyEndocrine-related CancerWomen's HealthMenopause Hormone Therapy